Zhitong Finance and Economics APP news, Hainan Huluwa Pharmaceutical Group (605199.SH) announced to improve the financial strength and comprehensive competitiveness of Hainan Huluwa Pharmaceutical Co., Ltd. (referred to as "Hainan Huluwa"), promote the healthy operation and sustainable development of Hainan Huluwa, the company intends to increase the capital of Hainan Huluwa by 0.29 billion yuan through debt-for-equity swaps. After this capital increase, the registered capital of Hainan Huluwa will increase from 10 million yuan to 0.3 billion yuan. After the capital increase, Hainan Huluwa will still be a wholly-owned subsidiary of the company.